Ibuzatrelvir not checked

Pfizer · PF-07817883

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
11 in total · 4 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
COVID-19 Infection, COVID-19 SARS-CoV-2 Infection
Main trialPhase 3
“This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized at baseline with mild-to-moderate COVID-19.”In the company’s words, NCT07013474 on ClinicalTrials.gov
Other names
PF-07817883

Other drugs for COVID-19 Infection

All 44 drugs for COVID-19 Infection

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 28 Sep 2027 A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3Recruiting 1 Oct 2027 A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Phase 2Completed 13 Sep 2023 A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized
Phase 1Completed 10 Jul 2023 A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.
Phase 1Completed 15 Sep 2023 A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People
Phase 1Completed 12 Jan 2024 A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers
Phase 1Completed 27 Jun 2024 A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.
Phase 1Completed 15 Jan 2025 A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults
Phase 1Completed 17 Jan 2025 A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults
Phase 1Completed 13 Feb 2025 A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
Phase 1Completed 21 Nov 2025 A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Ibuzatrelvir

Following is part of Solo: you see every change to Ibuzatrelvir the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in